INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 195 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $7,602,000 | -20.6% | 45,835 | +15.5% | 0.02% | -8.0% |
| Q2 2015 | $9,576,000 | -53.1% | 39,671 | -45.2% | 0.02% | -51.9% |
| Q1 2015 | $20,426,000 | -52.2% | 72,428 | -59.9% | 0.05% | -51.4% |
| Q3 2014 | $42,720,000 | -55.9% | 180,491 | -55.9% | 0.11% | -2.7% |
| Q2 2014 | $96,846,000 | +1916.8% | 409,270 | +481.9% | 0.11% | +900.0% |
| Q4 2013 | $4,802,000 | -53.8% | 70,334 | -53.3% | 0.01% | -54.2% |
| Q3 2013 | $10,389,000 | +52.5% | 150,501 | -0.9% | 0.02% | +50.0% |
| Q2 2013 | $6,812,000 | – | 151,913 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |